AHA Statement on Potential New Payment Model for Part B Drugs

 

 

Rick Pollack

AHA President and CEO

October 25, 2018

 

 

America’s hospitals and health systems are pleased that President Trump and his administration are focused on reining in out-of-control drug prices, which continue to threaten patient access and the ability of providers to deliver the highest quality of care. We look forward to reviewing the details of the model closely, including its impact on 340B hospitals and the patients they serve.

 

About the American Hospital Association

The AHA is a not-for-profit association of health care provider organizations and individuals that are committed to the improvement of health in their communities. The AHA is the national advocate for its members, which include nearly 5,000 hospitals, health care systems, networks and other providers of care. Founded in 1898, the AHA provides education for health care leaders and is a source of information on health care issues and trends. For more information, visit https://www.aha.org.

 

Contact: 

 

Marie Johnson, (202) 626-2351

Colin Milligan, (202) 638-5491

 

 

###

Related Resources

Press Releases
Infographics
Public
Guides/Reports
Public
The American Hospital Association (AHA), the Federation of American Hospitals (FAH), and the American Society of Health-System Pharmacists (ASHP) released a…
Letter
Public
AHA comments on the Centers for Medicare…
Letter
Public
The AHA voiced support for a Centers for Medicare & Medicaid Services’ proposal to require drug pricing transparency in direct-to-consumer tele
Special Bulletin
Member
Special Bulletin on CMS’s Nov. 26 proposed rule aimed at lowering drug prices for beneficiaries enrolled in Medicare Advantage and Part D programs.